Do You Qualify for Defitelio Coverage by UnitedHealthcare in Illinois? Decision Tree & Next Steps

Answer Box: Quick Eligibility Assessment

You likely qualify for Defitelio (defibrotide) coverage by UnitedHealthcare in Illinois if you have hepatic veno-occlusive disease (VOD/SOS) with organ dysfunction after stem cell transplant. The fastest path is submitting prior authorization through OptumRx with complete transplant documentation. If denied, Illinois law guarantees external review within 30 days with binding decisions. Start today: Gather your transplant records, confirm your diagnosis meets FDA criteria, and have your transplant team initiate the PA request.

Table of Contents

  1. How to Use This Guide
  2. Eligibility Triage: Do You Qualify?
  3. If You're Likely Eligible
  4. If You're Possibly Eligible
  5. If You're Not Yet Eligible
  6. If You've Been Denied
  7. Coverage Requirements at a Glance
  8. Appeals Playbook for Illinois
  9. Cost Assistance Options
  10. FAQ

How to Use This Guide

This decision tree helps you navigate Defitelio (defibrotide) coverage with UnitedHealthcare in Illinois. Start with the eligibility triage below to understand your approval likelihood, then follow the appropriate pathway. Each section includes specific documents needed, submission instructions, and timelines.

Note: This guide applies to Illinois-regulated UnitedHealthcare plans. Self-insured employer plans follow federal ERISA rules and may have different appeal processes.

Eligibility Triage: Do You Qualify?

Likely Eligible - Strong Approval Chances

You meet these criteria:

  • Confirmed diagnosis: Hepatic VOD/SOS with renal and/or pulmonary dysfunction
  • Post-transplant setting: After hematopoietic stem cell transplantation (HSCT)
  • Meets diagnostic criteria: Two or more Cairo/Cooke criteria including bilirubin ≥2 mg/dL
  • Transplant center involvement: Diagnosed and managed at an accredited transplant facility
  • Organ dysfunction documented: Labs and imaging showing kidney or lung complications

⚠️ Possibly Eligible - Additional Documentation Needed

You have:

  • VOD/SOS diagnosis but missing complete organ dysfunction documentation
  • Post-transplant complications but unclear if they meet specific diagnostic thresholds
  • Treatment at a facility that's not a designated transplant center
  • Incomplete baseline pre-transplant labs for comparison

Not Yet Eligible - Consider Alternatives First

Your situation includes:

  • VOD/SOS prophylaxis (prevention) rather than treatment of established disease
  • No documented stem cell transplant history
  • Coagulopathy or bleeding disorders that contraindicate treatment
  • Missing fundamental diagnostic criteria despite clinical suspicion

If You're Likely Eligible

Document Checklist

Gather these materials before starting your prior authorization:

Essential Clinical Documentation:

  • Complete transplant records including conditioning regimen and dates
  • Laboratory results showing bilirubin ≥2 mg/dL (or ≥34.2 micromoles/L)
  • Evidence of organ dysfunction (creatinine, imaging, pulmonary function)
  • Pre-transplant baseline values for comparison
  • Current weight and documentation of ≥5% weight gain from baseline

Administrative Requirements:

Submission Path

Step 1: Your transplant team submits the PA request through the UnitedHealthcare Provider Portal or fax to OptumRx.

Step 2: OptumRx reviews within 15 business days for standard requests, 72 hours for urgent cases.

Step 3: If approved, Defitelio ships from Optum Specialty Pharmacy within 24-48 hours.

Tip: Request expedited review if treatment delay would seriously jeopardize your health. Include physician certification of clinical urgency.

If You're Possibly Eligible

Additional Tests to Request

Work with your transplant team to obtain:

Diagnostic Confirmation:

  • Doppler ultrasound to assess portal flow reversal
  • Complete metabolic panel with liver function tests
  • Coagulation studies (PT/INR, PTT)
  • Imaging to document ascites or hepatomegaly

Documentation Improvements:

  • Detailed transplant timeline and conditioning regimen used
  • Baseline pre-transplant measurements for comparison
  • Second opinion from transplant hepatologist if available

Timeline to Re-apply

Once you have complete documentation, resubmit your PA request. Most "incomplete" denials can be overturned with proper clinical records within 2-4 weeks.

If You're Not Yet Eligible

Alternatives to Discuss

Supportive Care Options:

  • Fluid management and diuretics for volume overload
  • Renal replacement therapy if indicated
  • Pulmonary support measures
  • Close monitoring for progression to treatment criteria

Preparing for Exception Requests

If your clinical situation is urgent but doesn't meet standard criteria:

  • Document why standard criteria may not apply to your case
  • Gather supporting literature for off-label or compassionate use
  • Request peer-to-peer review with UnitedHealthcare medical director
  • Consider contacting Jazz Pharmaceuticals for expanded access programs

If You've Been Denied

Illinois residents have strong appeal rights with binding external review. Here's your pathway:

Internal Appeal (First Step)

Timeline: File within 180 days of denial notice Process: Submit through UnitedHealthcare member portal or mail appeal letter Decision deadline: 15 business days (24 hours if expedited) Success factors: Address specific denial reasons with additional clinical evidence

External Review (If Internal Appeal Fails)

Timeline: Request within 30 days of final internal denial (shorter than most states) Process: Submit Illinois Department of Insurance External Review form Decision: Binding within 45 days (72 hours if expedited) Cost: Free to patients; insurer pays review fees

Submit to: Illinois Department of Insurance
Office of Consumer Health Insurance
EXTERNAL REVIEW REQUEST
320 W. Washington St, Springfield, IL 62767
Fax: 217-557-8495
Email: [email protected]

Critical: Illinois' 30-day external review deadline is shorter than the federal 4-month standard. Don't delay if your internal appeal is denied.

Coverage Requirements at a Glance

Requirement Details Where to Verify
Prior Authorization Required for all plans OptumRx PA Guidelines
Diagnosis Hepatic VOD/SOS with organ dysfunction FDA Prescribing Information
Setting Post-HSCT only UnitedHealthcare Medical Policy
Dispensing Optum Specialty Pharmacy only UHC Specialty Network
Supply Limit Maximum 30-day fills OptumRx Formulary
Appeals Deadline 30 days for external review Illinois DOI

Appeals Playbook for Illinois

Level 1: Internal Appeal

  • Who: UnitedHealthcare internal reviewers
  • Deadline: 180 days from denial
  • Decision time: 15 business days (24 hours expedited)
  • Submit via: Member portal or mail

Level 2: External Review

  • Who: Independent physician reviewer
  • Deadline: 30 days from final internal denial
  • Decision time: 45 days (72 hours expedited)
  • Result: Binding on UnitedHealthcare

Help Available

  • Illinois Department of Insurance: 1-877-850-4740
  • Illinois Attorney General Health Care Helpline: 1-877-305-5145

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, payer policies, and clinical documentation to craft targeted, evidence-backed responses. Their platform helps patients and providers navigate complex prior authorization requirements and appeal processes for specialty medications like Defitelio.

Cost Assistance Options

Jazz Pharmaceuticals Support

JazzCares Program offers multiple assistance options:

  • Copay assistance: For commercially insured patients (including UnitedHealthcare)
  • Patient assistance program: Free drug for eligible uninsured patients
  • Contact: 1-833-533-JAZZ (5299)
  • Eligibility: US residents with valid prescription

Financial Criteria

  • Income less than 400% of Federal Poverty Level for free drug program
  • Commercial insurance copay support subject to annual maximums
  • Application available online

Frequently Asked Questions

Q: How long does UnitedHealthcare prior authorization take for Defitelio? A: Standard PA decisions within 15 business days; expedited reviews within 72 hours if clinically urgent.

Q: What if Defitelio isn't on my formulary? A: Non-formulary status doesn't prevent coverage. Submit PA request with medical necessity documentation.

Q: Can I get an expedited appeal in Illinois? A: Yes, both internal and external reviews offer expedited timelines (24-72 hours) when delay would jeopardize health.

Q: What happens if UnitedHealthcare denies my external review request? A: External review decisions are binding in Illinois. If the independent reviewer approves coverage, UnitedHealthcare must provide it.

Q: Does step therapy apply to Defitelio? A: No standard alternatives exist for hepatic VOD/SOS treatment, so step therapy typically doesn't apply.

Q: What if I have a self-insured employer plan? A: ERISA plans follow federal appeal processes only. Illinois external review doesn't apply, but you can still appeal through your plan's internal process.


From our advocates: We've seen Illinois patients successfully overturn Defitelio denials by working closely with their transplant teams to document organ dysfunction clearly. The key is often getting pre-transplant baseline labs for comparison and ensuring all diagnostic criteria are explicitly addressed in the medical necessity letter. While outcomes vary, thorough documentation significantly improves approval chances.

For complex appeals requiring detailed policy analysis and evidence compilation, Counterforce Health provides specialized support in crafting targeted responses to insurance denials.

Sources & Further Reading


Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual plan terms and clinical circumstances. Always consult your healthcare provider and insurance policy for specific guidance. For additional help with Illinois insurance issues, contact the Illinois Department of Insurance at 1-877-850-4740.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.